J Am Acad Dermatol 45:7785 Barnhill RL, Cerroni L, Cook M et al (2010) State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop
RSI: rapid sequence induction PRACTICAL RECOMMENDATIONS Clinicians should be aware of the potential perioperative risk in patients receiving GLP-1RAs, GIP/ GLP-1RA and SGLT2 inhibitors
The most common side effects of semaglutide are gastrointestinal, like nausea, vomiting, and diarrhea
Key Takeaway: There is no universal cycle length for glutathione
GLP-1s aren't recommended for cosmetic weight loss:These are FDA-approved for: People with obesity (BMI 30) BMI 27 with serious weight-related health issues T2D, high blood pressure, fatty liver disease For severe obesity with metabolic disorders, they can be life-changing.Thanks for reading